Tag: Prescription Drugs
Psoriasis Tx Linked to Drop in Noncalcified Coronary Plaque
Noncalcified plaque burden and necrotic core reduced in association with biologic therapy
Tofacitinib Benefits Sustained for Two Years in Patients With RA
Safety, tolerability through 24 months was consistent with 12-month tofacitinib analysis
Pharmacist-Led Phone Follow-Up May Cut Readmission Rates
Intervention for polypharmacy patients linked to improved readmission rates, time to readmission
Discontinuing TNFi Before Gestational Week 20 Is Feasible
No clinically meaningful disease worsening among women with well-controlled RA, juvenile arthritis
Shortage of Anxiety Drug Creates Alarm Among Patients, Doctors
Buspirone price has fallen so low that many manufacturers claim they cannot make a profit on it
Methotrexate Well Tolerated, Effective for Psoriasis in Chinese
Greater therapeutic response, fewer adverse events seen in those without psoriatic arthritis
Off-Label Uses in Dermatology Often Missing From Compendia
Only 30.7 percent of 238 treatments used to treat 22 dermatologic conditions listed in compendia
NOACs Recommended as First-Line Prevention of Stroke in A-Fib
Updated guidelines also emphasize weight loss for overweight, obese patients with atrial fibrillation
Risk for Conversion of MS Varies With Different Therapies
Lower risk for conversion for initial treatment with fingolimod, alemtuzumab, or natalizumab
2003 to 2015 Saw Increase in Outpatient Benzodiazepine Use
Fourfold increase seen in rate of coprescribing with opioids; twofold increase with other sedating meds
